RxDoctor Payments DataLook up a doctor →

Neal Erickson, MD

Family Medicine · Overland Park, KSNPI 1164427860

Payments from drug & device makers

$13,277in general payments, 2019–2025

Across 855 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$964
  • Amgen$727
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)117$1,653
AstraZeneca73$1,297
Pfizer76$1,035
Novo Nordisk75$1,006
Lilly USA, LLC55$964
Amgen50$727
Boehringer Ingelheim24$439
Antares Pharma, Inc.26$414
GSK30$400
Merck25$309
Johnson & Johnson19$301
Sanofi-aventis U.S. LLC17$285
Daiichi Sankyo Inc.12$274
Corium, LLC12$247
Takeda Pharmaceuticals U.S.A., Inc.14$206
Collegium Pharmaceutical, Inc.14$205
Eisai Inc.12$193
Amarin Pharma, Inc.15$189
Supernus Pharmaceuticals, Inc.11$187
Otsuka America Pharmaceutical, Inc.10$185
Axsome Therapeutics, Inc.9$176
Sumitomo Pharma America, Inc.9$162
Esperion Therapeutics, Inc.8$128
Astellas Pharma US Inc8$120
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$118
Kowa Pharmaceuticals America, Inc.8$115
Shire North American Group Inc7$110
Biohaven Pharmaceuticals, Inc.7$109
Novartis8$99
Ironshore Pharmaceuticals Inc.5$98
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$90
Alnylam Pharmaceuticals Inc.5$77
Phathom Pharmaceuticals, Inc.5$72
Biohaven Pharmaceutical Holding Company Ltd.4$71
Idorsia Pharmaceuticals US Inc4$68
Radius Health, Inc.2$67
Bayer4$67
Jazz Pharmaceuticals Inc.4$63
Abbott3$58
Teva Pharmaceuticals USA, Inc.4$56
Nevro Corp.3$51
Vertex2$46
Neos Therapeutics, LP3$46
Fidia Pharma USA Inc.2$45
Exeltis, USA Inc.3$39
Scilex Pharmaceuticals Inc.2$37
Lundbeck LLC2$36
Ironwood Pharmaceuticals, Inc2$32
Halozyme Inc2$31
Exact Sciences2$31
E.r. Squibb & Sons, L.L.C.2$29
Upsher-smith Laboratories LLC1$24
Clarus Therapeutics Inc.2$23
Nestle Healthcare Nutrition Inc.1$23
Sanofi1$22
Neurelis, Inc.1$20
Pharmacosmos Therapeutics Inc.1$19
UCB, Inc.1$18
Alkermes, Inc.1$18
Therapeuticsmd, Inc.1$16

How this compares

$13,277 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$324,171
Medicare patients
1,067
Services billed
7,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →